zepbound tirzepatide side effects Lawsuit [2026 Update] A Guide to Zepbound Side

doi:10.1186/s12866-019-1552-1 145

Similarly, the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) [47] and the Study of Heart and Kidney Protection with Empagliflozin (EMPA-KIDNEY) [48] trials expanded inclusion beyond diabetes mellitus, showing that dapagliflozin and empagliflozin significantly reduced the risk of kidney outcomes, with consistent benefits across a wide range of eGFR and albuminuria

SGLT2 inhibitors have varying eGFR thresholds depending on the specific agent and indication

"Arginine" and "L-arginine" are often used interchangeably and used to refer to the same thing